Users of the Dexcom G5 Mobile Continuous Glucose Monitoring System (Dexcom G5) can now rely on the device to make diabetes treatment decisions using two finger pricks daily, not multiple ones, following the U.S. Food and Drug Administration’s (FDA) approval…
Read more
A cure for diabetes could be imminent after scientists discovered how to make huge quantities of insulin-producing cells, in a breakthrough hailed as significant as antibiotics. Harvard University has, for the first time, managed to manufacture the millions of beta…
Read more
Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called bacillus Calmette-Guerin (BCG), in 150 adults with advanced cases of…
Read more
So its official. We are continuously monitoring glucose! We started on the Dexcom G4 Platinum system with Share. Although not brand new technology, it is new to us and we were ready to give it a try. After navigating the…
Read more
Scientists are hopeful that “smart insulins which are undergoing trials could revolutionize the way diabetes is managed.
Between their partnership with Selecta for a T1D vaccine as referenced below and their partnership with Smartcells on “Smart Insulin”, the JDRF is coming at the issue of T1D from many angles. These developments are still years away (although Smart…
Read more
Continues Integration of Abbott’s FreeStyle(R) Technology with Insulet’s OmniPod(R) Insulin Management System BILLERICA, MA — (Marketwired) — 02/03/15 — Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod®Insulin Management System, today announced that it has…
Read more